Centinel Spine announced the completion of the 2,500th case in the U.S. with the prodisc C Vivo and prodisc C SK Cervical TDR System. This follows the milestone of the 1,000th case reported in April 2023.
The technologies are part of the new Match-the-Disc System made available in a limited release in 4Q22. Over 350 surgeons have used the new system over the last 12 months; nearly 70% are repeat users.
The prodisc portfolio offers both cervical and lumbar implants with anatomically-differentiated designs. Centinel Spine is the only company with FDA approval for both cervical and lumbar TDR systems. All of the prodisc cervical and lumbar devices incorporate prodisc CORE technology, the basis behind the predictable clinical outcomes of the prodisc platform after 30 years and over 250,000 implantations worldwide.
Centinel Spine announced the completion of the 2,500th case in the U.S. with the prodisc C Vivo and prodisc C SK Cervical TDR System. This follows the milestone of the 1,000th case reported in April 2023.
The technologies are part of the new Match-the-Disc System made available in a limited release in 4Q22. Over 350 surgeons have used the...
Centinel Spine announced the completion of the 2,500th case in the U.S. with the prodisc C Vivo and prodisc C SK Cervical TDR System. This follows the milestone of the 1,000th case reported in April 2023.
The technologies are part of the new Match-the-Disc System made available in a limited release in 4Q22. Over 350 surgeons have used the new system over the last 12 months; nearly 70% are repeat users.
The prodisc portfolio offers both cervical and lumbar implants with anatomically-differentiated designs. Centinel Spine is the only company with FDA approval for both cervical and lumbar TDR systems. All of the prodisc cervical and lumbar devices incorporate prodisc CORE technology, the basis behind the predictable clinical outcomes of the prodisc platform after 30 years and over 250,000 implantations worldwide.
Copy to clipboard 
